Cisplatin in cancer therapy: Molecular mechanisms of action
2014/07/21 by Shaloam Dasari, Paul Bernard Tchounwou · 46 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Metal complexes synthesis and properties #Chemotherapy-induced organ toxicity mitigation #Cancer therapeutics and mechanisms
paper · doi:10.1016/j.ejphar.2014.07.025
Citations
Cited by
- Organometallic conjugates of artesunate: synthesis and evaluation of anticancer potential
- Cisplatin Exposure Dysregulates Insulin Secretion in Male and Female Mice
- Significant Radiation Enhancement Effects by Gold Nanoparticles in Combination with Cisplatin in Triple Negative Breast Cancer Cells and Tumor Xenografts
- An Antitumor Bis(N‐Heterocyclic Carbene)Platinum(II) Complex That Engages Asparagine Synthetase as an Anticancer Target
- The impact of genetic background on mouse models of kidney disease
- Targeting DNA damage repair pathways in pancreas cancer
- Ru(II)-Arene Complexes of Pyrazole-Based Acylthiourea for Anticancer Application against Ovarian Cancer Cell Lines: Effect of Arene, Halido, and Acylthiourea Ligands
- The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer
- Advances in anticancer applications of platinum(II) complexes of dithiocarbamates
- Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies
- Platinum-based drugs for cancer therapy and anti-tumor strategies
- R-type ginsenoside Rg3 attenuates cisplatin-induce intestinal injury via restoring autophagy flux blockade
- β‐ TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
- Engineering oxaliplatin( iv ) prodrugs with monohaloacetates for redox-responsive and multimodal anticancer activity
- Intercalation Favors DNA Covalent Photobinding in Photoresponsive Dual PDT/PCT Bimetallic Assemblies
- Self-organization of the hematopoietic vascular niche and emergent innate immunity on a chip
- The salutary action of melatonin and betaine, given singly or concomitantly, on cisplatin-induced nephrotoxicity in mice
- New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas
- MicroRNA‐1 overexpression increases chemosensitivity of non‐small cell lung cancer cells by inhibiting autophagy related 3‐mediated autophagy
- Reduction of Platinum(IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor‐Targeted Therapeutically Enhanced Anticancer Therapy
- The Seven-Year Drought, Household Food Security and Vulnerable Groups in Botswana
- Enzyme‐Activatable Chemokine Conjugates for In Vivo Targeting of Tumor‐Associated Macrophages
- DNA repair mechanisms in cancer development and therapy. [europepmc]
- Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. [europepmc]
- Mechanisms of DNA damage, repair, and mutagenesis. [europepmc]
- Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. [europepmc]
- Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. [europepmc]
- Cisplatin is retained in the cochlea indefinitely following chemotherapy. [europepmc]
- Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection. [europepmc]
- The Akt pathway in oncology therapy and beyond (Review). [europepmc]
- Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. [europepmc]
- Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. [europepmc]
- GRP78: A cell's response to stress. [europepmc]
- Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury. [europepmc]
- STING pathway agonism as a cancer therapeutic. [europepmc]
- New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment. [europepmc]
- Ovarian damage from chemotherapy and current approaches to its protection. [europepmc]
- Understanding of ROS-Inducing Strategy in Anticancer Therapy. [europepmc]
- Partitioning of cancer therapeutics in nuclear condensates. [europepmc]
- Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy. [europepmc]
- Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets. [europepmc]
- The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity. [europepmc]
- L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine. [europepmc]
- Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations. [europepmc]
- Chemotherapy: a double-edged sword in cancer treatment. [europepmc]
- Chemotherapy Side-Effects: Not All DNA Damage Is Equal. [europepmc]
- Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. [europepmc]